New hope for hard-to-treat myeloma: experimental drug LBL-034 enters human trials

NCT ID NCT06049290

Recruiting now Disease control Sponsor: Nanjing Leads Biolabs Co.,Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called LBL-034 in people whose multiple myeloma has returned or no longer responds to standard treatments. The trial has two phases: first, finding the safest dose, and then checking how well the drug shrinks tumors. About 342 adults will take part across multiple centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RELAPSED/REFRACTORY MULTIPLE MYELOMA

Contacts and locations

Locations

Fujian Medical University Union Hospital
NOT_YET_RECRUITING

Fuzhou, Fujian, 350000, China
Henan Cancer Hospital
NOT_YET_RECRUITING

Zhengzhou, Henan, 450008, China
Institute of hematology & blood diseases hospital, chinese academy of medical sciences & peking union medical college
NOT_YET_RECRUITING

Tianjin, Tianjin Municipality, 300000, China
Peking University People's Hospital
RECRUITING

Beijing, Beijing Municipality, 100044, China
Peking University Shougang Hospital
NOT_YET_RECRUITING

Beijing, Beijing Municipality, 100144, China
Qingdao Municipal Hospital
RECRUITING

Qingdao, Shandong, 266011, China
Shanghai Fourth People's Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200000, China
Shanxi Bethune Hospital
RECRUITING

Taiyuan, Shanxi, 030000, China
Shengjing Hospital of China Medical University
RECRUITING

Shengyang, Liaoning, 117004, China
Shenzhen Second People's Hospital
RECRUITING

Shenzhen, Guangdong, 518035, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 516000, China
The Afliliated Hospital of Guizhou Medical Univeristy
RECRUITING

Guiyang, Guizhou, 563000, China
The First Affiliated Hospital Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 310000, China
The First Affiliated Hospital of Henan University
RECRUITING

Luoyang, Henan, 471003, China
The First Affiliated Hospital of Ningbo University
RECRUITING

Ningbo, Zhejiang, 315000, China
The First Affiliated Hospital of Soochow University
NOT_YET_RECRUITING

Suzhou, Jiangsu, 215006, China
The First Affiliated Hospital of Wannan Medical College
RECRUITING

Wuhu, Anhui, 241001, China
The First Affiliated Hospital of Wenzhou Medical University
RECRUITING

Wenzhou, Zhejiang, 325000, China
The First Affiliated Hospital of Xi'an Jiao Tong University
NOT_YET_RECRUITING

Xi’an, Shanxi, 710061, China
The First Affiliated Hospital of Xiamen University
RECRUITING

Xiamen, Fujian, 361000, China
The First Affiliated Hospital of Zhengzhou University
NOT_YET_RECRUITING

Zhengzhou, Henan, 450052, China
The First Bethune Hospital of Jilin University
RECRUITING

Changchun, Jilin, 130000, China
The Second Affiliated Hospital of Hainan Medical University
RECRUITING

Haikou, Hainan, 570000, China
The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital)
RECRUITING

Xi’an, Shanxi, 710004, China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITING

Wuhan, Hubei, 430000, China
Xiangya Hospital of Central South University
NOT_YET_RECRUITING

Changsha, Hunan, 410008, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.